BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 8401094)

  • 1. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    Hum Reprod; 1994 Nov; 9(11):2167-72. PubMed ID: 7868693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study.
    Henshaw R; Naji S; Russell I; Templeton A
    Acta Obstet Gynecol Scand; 1994 Nov; 73(10):812-8. PubMed ID: 7817735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
    Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of abortion in early pregnancy with mifepristone in conjunction with gemeprost.
    Somell C; Olund A
    Acta Obstet Gynecol Scand; 1993 Jan; 72(1):39-42. PubMed ID: 8382430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative cervical preparation before first trimester vacuum aspiration: a randomized controlled comparison between gemeprost and mifepristone (RU 486).
    Henshaw RC; Templeton AA
    Br J Obstet Gynaecol; 1991 Oct; 98(10):1025-30. PubMed ID: 1751434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost.
    Norman JE; Thong KJ; Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1992 Jul; 99(7):601-6. PubMed ID: 1525104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's evaluation of three early abortion methods.
    Holmgren K
    Acta Obstet Gynecol Scand; 1992 Dec; 71(8):616-23. PubMed ID: 1336921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of acceptability of RU486 and ONO 802 in a Chinese population.
    Tang GW
    Contraception; 1991 Nov; 44(5):523-32. PubMed ID: 1797467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
    Ulmann A; Silvestre L; Chemama L; Rezvani Y; Renault M; Aguillaume CJ; Baulieu EE
    Acta Obstet Gynecol Scand; 1992 May; 71(4):278-83. PubMed ID: 1322621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised study of two doses of gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Thong KJ; Lynch P; Baird DT
    Contraception; 1996 Aug; 54(2):97-100. PubMed ID: 8842586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) or the antiprogestogen RU 486.
    Cameron IT; Baird DT
    Br J Obstet Gynaecol; 1988 Mar; 95(3):271-6. PubMed ID: 3370199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
    Tang GW; Lau OW; Yip P
    Contraception; 1993 Sep; 48(3):267-76. PubMed ID: 8222656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion.
    Urquhart DR; Templeton AA
    Br J Obstet Gynaecol; 1991 Apr; 98(4):396-9. PubMed ID: 2031899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary.
    Martin CW; Brown AH; Baird DT
    Contraception; 1998 Aug; 58(2):99-103. PubMed ID: 9773264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.